Broadcast Date: 
  • Time: 

In this webinar, we will present the latest advances and challenges facing researchers focused on new and emerging modalities in drug discovery. Topics will include targeted protein degradation, targeted covalent inhibitors, and nucleic acid therapeutics. Our expert speaker will discuss solutions for addressing the complexities in designing, synthesizing, and optimizing these molecules, with an added focus on the special modifications and delivery systems needed for siRNAs and ASOs. 

Discussion topics:

  • Challenges in developing next-generation therapeutics based on new modalities such as targeted protein degraders, targeted covalent inhibitors, and nucleic acids (such as ASOs and siRNAs)
  • Resources available when using a global open access platform
  • Latest advances and technologies in new modalities

A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelist.

Tao Guo
Tao Guo, PhD
SVP and Head of WuXi Chemistry-RCS BD&IPM
WuXi AppTec


Comments are closed.